GPP and Me

28 October 2021

By Boehringer Ingelheim

Boehringer Ingelheim raises awareness of Generalized Pustular Psoriasis

Boehringer Ingelheim is proud to support IFPA and other organisations, uniting to raise awareness of all psoriatic diseases during World Psoriasis Day (WPD) 2021. 

As part of this united approach, BI is marking WPD by raising awareness for Generalised Pustular Psoriasis (GPP), a rare neutrophilic skin disease. 

GPP sometimes gets confused with severe plaque psoriasis, but is a distinctly different disease. Episodes or flares of widespread reddened, inflamed skin with painful pus-filled blisters that can cover large parts of the body - with or without general symptoms such as fever, joint pain, or feeling extremely tired.  There may be other health concerns with GPP, such as infections or other organ involvement that, although rare, could be life-threatening. GPP can affect other aspects of life, including mental health, the ability to socialize and performing other daily activities.  

Boehringer Ingelheim marks 2021 WPD with the launch of the first dedicated GPP patient information website:, providing patients with access to information about GPP.

Visitors to the website can learn facts about GPP, how’s it’s different from Plaque Psoriasis as well as hear from people living with GPP. 

We encourage visitors to IFPA’s WPD map to explore the website and appreciate your feedback.